<--- Back to Details
First PageDocument Content
Government / Pharmaceutical sciences / Center for Devices and Radiological Health / Medicaid / Food and Drug Administration / Jeffrey Shuren / Health
Date: 2014-09-23 13:44:07
Government
Pharmaceutical sciences
Center for Devices and Radiological Health
Medicaid
Food and Drug Administration
Jeffrey Shuren
Health

Bio JEFFREY SHUREN, MD, JD is the Director of the Center for Devices and Radiological Health (CDRH) at FDA. He previously served as Acting Center Director. Dr. Shuren has held various policy and planning positions within

Add to Reading List

Source URL: www.ecri.org

Download Document from Source Website

File Size: 45,79 KB

Share Document on Facebook

Similar Documents

Jeffrey Shuren, M.D., J.D. Director Center for Devices and Radiological Health Food and Drug AdministrationNew Hampshire Avenue Silver Spring, MD

DocID: 1tLOR - View Document

Digital Health Innovation Action Plan  Introduction FDA’s Center for Devices and Radiological Health (CDRH) puts patients at the forefront of our vision—we are driven by timely patient access to high-quality, s

DocID: 1ttzz - View Document

Post-doctoral fellow position #2 – Research Focus Nanotechnology/nanotoxicology - Safety of engineered nanomaterials The Center for Devices and Radiological Health, US Food and Drug Administration, Silver Spring, Maryl

DocID: 1sM2j - View Document

Sunlamps: Regulatory Issues W. Howard Cyr, Ph.D. Office of Science and Technology, Center for Devices and Radiological Health, Food and Drug Administration, Rockville, MD USA For distribution at the following meetings:

DocID: 1srEV - View Document

Food and Drug Administration / Health / Food law / Pharmaceuticals policy / Personal life / Pharmaceutical industry / Healthcare quality / Federal Food /  Drug /  and Cosmetic Act / Medical device / Validation / Center for Devices and Radiological Health / RNA-Seq

Use of Standards in FDA Regulatory Oversight of Next Generation Sequencing (NGS)-Based In Vitro Diagnostics (IVDs) Used for Diagnosing Germline Diseases - Draft Guidance for Stakeholders and Food and Drug Administration

DocID: 1rmMY - View Document